[
  {
    "ts": "2025-09-11T16:49:11+00:00",
    "headline": "Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the Blue Chip Stocks to Buy with the Lowest PE Ratios. On September 8, Amgen Inc. (NASDAQ:AMGN), along with Kyowa Kirin preliminary top-line results from the ASCEND study of Rocatinlimab in moderate to severe atopic dermatitis. Rocatinlimab is an experimental T-cell therapy targeting the OX40 receptor, which aims to rebalance […]",
    "url": "https://finance.yahoo.com/news/amgen-inc-amgn-releases-top-164911648.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "5d5d1f8a-043d-318a-b23d-08ca63259804",
      "content": {
        "id": "5d5d1f8a-043d-318a-b23d-08ca63259804",
        "contentType": "STORY",
        "title": "Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the Blue Chip Stocks to Buy with the Lowest PE Ratios. On September 8, Amgen Inc. (NASDAQ:AMGN), along with Kyowa Kirin preliminary top-line results from the ASCEND study of Rocatinlimab in moderate to severe atopic dermatitis. Rocatinlimab is an experimental T-cell therapy targeting the OX40 receptor, which aims to rebalance […]",
        "pubDate": "2025-09-11T16:49:11Z",
        "displayTime": "2025-09-11T16:49:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fl9k_iPg0JyfVI.qZJRd8A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RgojEqpZ8ITlaPGpQimL8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-inc-amgn-releases-top-164911648.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-inc-amgn-releases-top-164911648.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "4151.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]